Printable page for all IPOs that have date "scheduled".
This week's IPOs have bold border. Close Window


Company: Black Stone Minerals LP
Symbol: BSM
Price: $19.00-$21.00
Description: They are one of the largest owners of oil and natural gas mineral interests in the United States.
Trade Date: 5/1
Shares: 22.5 million
Type: IPO
Underwriter(s)   Co Manager(s)

Barclays, BofA Merrill Lynch, Citigroup, Credit Suisse, Wells Fargo   J.P. Morgan, Morgan Stanley, Raymond James,Scotia Howard Weil, Simmons & Company International


Company: Blueprint Medicines Corporation
Symbol: BPMC
Price: $15.00-$17.00
Description: They are a biopharmaceutical company focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation.
Trade Date: 4/30
Shares: 7.2 million
Type: IPO
Underwriter(s)   Co Manager(s)

Goldman Sachs & Co., Cowen and Company   JMP Securities, Wedbush PacGrow


Company: Colucid Pharmaceuticals
Symbol: CLCD
Price: $13.00-$15.00
Description: They are a Phase 3 clinical-stage biopharmaceutical company that is developing an innovative and proprietary small molecule for the acute treatment of migraine headaches.
Trade Date: 4/30
Shares: 5.4 million
Type: IPO
Underwriter(s)   Co Manager(s)

Piper Jaffray, Stifel   William Blair, Ladenburg Thalmann


Company: Enviva Partners LP
Symbol: EVA
Price: $19.00-$21.00
Description: They are the world's largest supplier by production capacity of utility-grade wood pellets to major power generators. Since our entry into this business in 2010, we have executed multiple long-term, take-or-pay off-take contracts with creditworthy customers and have built and acquired the production and terminaling capacity necessary to serve them.
Trade Date: 4/29
Shares: 10 million
Type: IPO
Underwriter(s)   Co Manager(s)

Barclays, Goldman Sachs & Co., RBC Capital Markets, Citigroup   J.P. Morgan, Raymond James, MUFG, U.S. Capital Advisors


Company: Gelesis, Inc.
Symbol: GLSS
Price: $12.00-$14.00
Description: They are a biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control, or management of blood sugar levels, in overweight and obese patients, including those with prediabetes and type 2 diabetes.
Trade Date: 5/6
Shares: 4 million
Type: IPO
Underwriter(s)   Co Manager(s)

Piper Jaffray, Stifel, Guggenheim Securities  


Company: MultiVir
Symbol: MVIR
Price: $12.00-$14.00
Description: They are a clinical-stage gene therapy company developing a pipeline of novel product candidates for the treatment of multiple oncological indications.
Trade Date: 5/6
Shares: 4.6 million
Type: IPO
Underwriter(s)   Co Manager(s)

RBC Capital Markets   Nomura, Cantor Fitzgerald & Co., LifeSci Capital


Company: Opgen, Inc.
Symbol: OPGN
Price: $5.50-$6.50
Description: They are an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections.
Trade Date: 4/28
Shares: 2.5 million
Type: IPO
Underwriter(s)   Co Manager(s)

Maxim Group LLC   National Securities Corporation


Company: Viking Therapeutics, Inc.
Symbol: VKTX
Price: $7.00-$9.00
Description: They are a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.
Trade Date: 4/29
Shares: 2.5 million
Type: IPO
Underwriter(s)   Co Manager(s)

Laidlaw & Company (UK) Ltd.   Feltl and Company,Inc.


Company: Yulong Eco-materials Ltd.
Symbol: YECO
Price: $6.25-$7.25
Description: They are the leading producer of fly-ash bricks and concrete in the city of Pingdingshan in Henan Province, China.
Trade Date: Week of 5/11
Shares: 2.25 million
Type: IPO
Underwriter(s)   Co Manager(s)

Axiom Capital Management, Inc.,Northland Capital Markets, ViewTrade Securities